Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,740,239,592
-
Number of holders
-
1801
-
Total 13F shares, excl. options
-
1,254,589,153
-
Shares change
-
-15,732,041
-
Total reported value, excl. options
-
$76,508,542,840
-
Value change
-
-$964,494,217
-
Put/Call ratio
-
64.61%
-
Number of buys
-
689
-
Number of sells
-
-860
-
Price
-
$60.99
Significant Holders of ABBOTT LABORATORIES - Common Stock (ABT) as of Q2 2018
1,925 filings reported holding ABT - ABBOTT LABORATORIES - Common Stock as of Q2 2018.
ABBOTT LABORATORIES - Common Stock (ABT) has 1,801 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,254,589,153 shares
of 1,740,239,592 outstanding shares and own 72.09% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (136,803,540 shares), Capital Research Global Investors (131,099,788 shares), BlackRock Inc. (116,149,740 shares), STATE STREET CORP (67,180,598 shares), WELLINGTON MANAGEMENT GROUP LLP (41,733,161 shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (39,138,499 shares), NORTHERN TRUST CORP (26,094,797 shares), MORGAN STANLEY (21,218,276 shares), WELLS FARGO & COMPANY/MN (20,322,141 shares), and GEODE CAPITAL MANAGEMENT, LLC (19,996,903 shares).
This table shows the top 1801 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.